Chronological improvement of survival in patients with advanced gastric cancer over 15 years
Therapeutic Advances in Medical Oncology · 2024-01 · 16
DOI: 10.1177/17588359241229428 ↗Kurz gefasst
Fachartikel in der Zeitschrift Therapeutic Advances in Medical Oncology, online erschienen am 09.02.2024. Verfasst von Takatsugu Ogata und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Recent trials have reported a median overall survival (OS) of 11–17 months in patients with advanced gastric cancer (AGC). However, it is unclear how recently approved drugs contribute to patient prognosis.
Objectives
We aimed to evaluate the characteristics and survival in patients with AGC over the past 15 years.
Design
Retrospective study.
Methods
We evaluated data of 1355 patients with AGC who received first-line chemotherapy between January 2005 and March 2019 at a single institution. We compared the characteristics and survival rates across four periods: January 2005–December 2007 (period A), January 2008–February 2011 (period B), March 2011–May 2015 (period C), and June 2015–March 2019 (period D). The median follow-up duration was 13.1 months, with 312, 333, 393, and 317 patients in periods A, B, C, and D, respectively.
Results
There were no significant differences in patient characteristics between the four periods, except for the proportion of patients who underwent prior gastrectomy and human epidermal growth factor receptor 2 (HER2) testing. Patients in period D had significantly longer OS than those in period A [median: 15.7 versus 12.4 months; adjusted hazard ratio (aHR): 0.79; p = 0.02]. The mean OS in patients with liver metastasis (LM) in period D was remarkably longer than that in patients in period A (median: 19.3 versus 12.4 months; aHR: 0.61; p < 0.01), while that in patients with peritoneal metastasis showed limited improvement.
Conclusion
Clinical strategy changes, including gastrectomy, HER2 testing, and approval of new drugs, may be associated with improved OS in patients with AGC. In the last 4 years, a remarkable improvement has been observed in patients with LM.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
- Department of Medical Oncology, Osaka International Cancer Institute, Osaka, Japan.
- Department of Clinical Oncology, Aichi Cancer Center Hospital, 1-1, Kanokoden, Chikusa-ku, Nagoya, Aichi 464-8681, Japan.
- Division of Cancer Epidemiology and Prevention, Department of Preventive Medicine, Aichi Cancer Center Research Institute, Nagoya, Japan.
- Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
- Department of Gastroenterological Surgery, Aichi Cancer Center Hospital, Nagoya, Japan.
ORCID-Profile: Takatsugu Ogata
Zitieren
APA
Ogata, T., Narita, Y., Oze, I., Kumanishi, R., Nakazawa, T., Matsubara, Y., Kodama, H., Nakata, A., Honda, K., Masuishi, T., Bando, H., Taniguchi, H., Kadowaki, S., Ando, M., Ito, S., Tajika, M., & Muro, K. (2024). Chronological improvement of survival in patients with advanced gastric cancer over 15 years. Therapeutic Advances in Medical Oncology, 16. https://doi.org/10.1177/17588359241229428
Vancouver
Ogata T, Narita Y, Oze I, Kumanishi R, Nakazawa T, Matsubara Y, et al. Chronological improvement of survival in patients with advanced gastric cancer over 15 years. Therapeutic Advances in Medical Oncology. 2024;16. doi:10.1177/17588359241229428
BibTeX
@article{Ogata2024,
author = {Ogata, Takatsugu and Narita, Yukiya and Oze, Isao and Kumanishi, Ryosuke and Nakazawa, Taiko and Matsubara, Yuki and Kodama, Hiroyuki and Nakata, Akinobu and Honda, Kazunori and Masuishi, Toshiki and Bando, Hideaki and Taniguchi, Hiroya and Kadowaki, Shigenori and Ando, Masashi and Ito, Seiji and Tajika, Masahiro and Muro, Kei},
title = {Chronological improvement of survival in patients with advanced gastric cancer over 15 years},
journal = {Therapeutic Advances in Medical Oncology},
year = {2024},
volume = {16},
doi = {10.1177/17588359241229428}
}
EUVIMED